Lucia Pedace

Lucia Pedace

Auto-generated profile, based on publicly available information

Lucia Pedace

Laboratorio di Neurogenetica CERC - IRCCS Santa Lucia Rome Italy

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Evelina MieleEvelina Miele
Evelina Miele
RVRita De Vito
Rita De Vito
ACAndrea Ciolfi
Andrea Ciolfi
LPLucia Pedace
Lucia Pedace
IRIda Russo
Ida Russo
GMGiuseppe Maria Milano
Giuseppe Maria Milano
Undifferentiated soft tissue sarcomas are a group of diagnostically challenging tumors in the pediatric population. Molecular techniques are instrumental for the categorization and differential diagnosis of these tumors. A subgroup of recently identified soft tissue sarcomas with undifferentiated round cell morphology was characterized by Capicua transcriptional receptor (CIC) rearrangements. Recently, an array-based DNA methylation analysis of undifferentiated tumors with small blue round cell histology was shown to provide a highly robust and reproducible approach for precisely classifying this diagnostically challenging group of tumors. We describe the case of an undifferentiated sarcoma of the abdominal wall in a 12-year-old girl. The patient presented with a voluminous mass of the abdominal wall, and multiple micro-nodules in the right lung. The tumor was unclassifiable with current immunohistochemical and molecular approaches. However, DNA methylation profiling allowed us to classify this neoplasia as small blue round cell tumor with CIC alterations. The patient was treated with neoadjuvant chemotherapy followed by complete surgical resection and adjuvant chemotherapy. After 22 months, the patient is disease-free and in good clinical condition. To put our experience in context, we conducted a literature review, analyzing current knowledge and state-of-the-art diagnosis, prognosis, and clinical management of CIC rearranged sarcomas. Our findings further support the use of DNA methylation profiling as an important tool to improve diagnosis of non-Ewing small round cell tumors.

Verified
Journal Article
Open access
PDF file
AFAidin Foroutan
Aidin Foroutan
SHSadegheh Haghshenas
Sadegheh Haghshenas
PBPratibha Bhai
Pratibha Bhai
MLMichael A. Levy
Michael A. Levy
JKJennifer Kerkhof
Jennifer Kerkhof
ALAnne-Sophie Lebre
Anne-Sophie Lebre
Wiedemann–Steiner syndrome (WDSTS) is a Mendelian syndromic intellectual disability (ID) condition associated with hypertrichosis cubiti, short stature, and characteristic facies caused by pathogenic variants in the KMT2A gene. Clinical features can be inconclusive in mild and unusual WDSTS presentations with variable ID (mild to severe), facies (typical or not) and other associated malformations (bone, cerebral, renal, cardiac and ophthalmological anomalies). Interpretation and classification of rare KMT2A variants can be challenging. A genome-wide DNA methylation episignature for KMT2A-related syndrome could allow functional classification of variants and provide insights into the pathophysiology of WDSTS. Therefore, we assessed genome-wide DNA methylation profiles in a cohort of 60 patients with clinical diagnosis for WDSTS or Kabuki and identified a unique highly sensitive and specific DNA methylation episignature as a molecular biomarker of WDSTS. WDSTS episignature enabled classification of variants of uncertain significance in the KMT2A gene as well as confirmation of diagnosis in patients with clinical presentation of WDSTS without known genetic variants. The changes in the methylation profile resulting from KMT2A mutations involve global reduction in methylation in various genes, including homeobox gene promoters. These findings provide novel insights into the molecular etiology of WDSTS and explain the broad phenotypic spectrum of the disease.

27 February 2024 in Cancer Letters
Verified
Journal Article
Closed access
Evelina MieleEvelina Miele
Evelina Miele
EAElena Anghileri
Elena Anghileri
CCChiara Calatozzolo
Chiara Calatozzolo
ELElisabetta Lazzarini
Elisabetta Lazzarini
SPSara Patrizi
Sara Patrizi
BPBianca Pollo
Bianca Pollo

1 May 2016 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
SKSeiji Kaji
Seiji Kaji
TKToshitaka Kawarai
Toshitaka Kawarai
RMRyosuke Miyamoto
Ryosuke Miyamoto
HNHiroyuki Nodera
Hiroyuki Nodera
LPLucia Pedace
Lucia Pedace
Ryuji KajiRyuji Kaji
Ryuji Kaji

9 February 2021 in Cancers
Verified
Journal Article
Open access
PDF file
OLOscar Lopez-Nunez
Oscar Lopez-Nunez
RARita Alaggio
Rita Alaggio
IJIvy John
Ivy John
ACAndrea Ciolfi
Andrea Ciolfi
LPLucia Pedace
Lucia Pedace
Evelina MieleEvelina Miele
Evelina Miele
MNTI is a rare tumor of indeterminate histogenesis and molecular signature. We performed methylation and copy number variation (CNV) profiles in patients with MNTI (n = 7) and PAT (n = 1) compared to the methylation brain tumor classifier v11b4 (BT-C) and the medulloblastoma (MB) classifier group 3/4 v1.0 (MB3/4-C). The patients’ mean age was 8 months (range: 4–48). The BT-C classified five MNTIs and one PAT (relapse) as class family MB-G3/G4, subclass group 3 (score: >0.9). The remaining two MNTIs and PAT (primary) were classified as class family plexus tumor, subclass pediatric (scores: >0.45). The MB3/4-C classified all MNTIs as high-risk MB-G3, Subtype II (score: >0.45). The primary PAT was classified as subtype III (score: 0.99) and its relapse as subtype II/III. MNTI and PAT clustered close to MB-G3. CNV analysis showed multiple rearrangements in one PAT and two MNTIs. The median follow-up was 54 months (four MNTIs in remission, one PAT died). In conclusion, we demonstrated that MNTI shares a homogenous methylation profile with MB-G3, and possibly with PAT. The role of a multipotent progenitor cell (i.e., early cranial neural crest cell) in their histogenesis and the influence of the anatomical site, tumor microenvironment, and other cytogenetic events in their divergent biologic behavior deserve further investigation.

25 March 2024 in European Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
MNMarcello Niceta
Marcello Niceta
ACAndrea Ciolfi
Andrea Ciolfi
MFMarco Ferilli
Marco Ferilli
LPLucia Pedace
Lucia Pedace
CCCamilla Cappelletti
Camilla Cappelletti
MTMarco Tartaglia
Marco Tartaglia